An outbreak of multi-drug-resistant Acinetobacter baumannii on a burns ICU and its control with multi-faceted
T Obenhuber1, T C Scheier1, T Stutz1
1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Background:
Patients in burns centres are at high risk of acquiring multi-drug-resistant organisms (MDROs) due to the reduced skin barrier and long hospital stay.
Methods:
This study reports the investigation and control of an outbreak of MDR Acinetobacter baumannii in a burns centre. The 27 patients hospitalized in the centre during the outbreak were screened regularly, and a total of 132 environmental samples were analysed to identify a potential source. Fourier-transform infra-red (FT-IR) spectroscopy and multi-locus sequence typing were applied to characterize the outbreak strain.
Results:
Between August and November 2022, the outbreak affected eight patients, with 11 infections and three potentially related fatal outcomes. An interdisciplinary and multi-professional outbreak team implemented a bundle strategy with repetitive admission stops, isolation precaution measures, patient screenings, enhanced cleaning and disinfection, and staff education. FT-IR spectroscopy suggested that the outbreak started from a patient who had been repatriated 1 month previously from a country with high prevalence of MDR A. baumannii. Environmental sampling did not identify a common source. Acquisition of the outbreak strain was associated with a higher percentage of body surface area with burn lesions ≥2a [per percent increase: odds ratio (OR) 1.05, 95% confidence interval (CI) 0.99-1.12; P=0.09], and inversely associated with a higher nurse-to-patient ratio (per 0.1 increase: OR 0.34, 95% CI 0.10-1.12; P=0.06).
Conclusions:
Burn patients with a higher percentage of body surface area with burn lesions ≥2a are at high risk of colonization and infection due to MDROs, particularly during periods of high workload. A multi-faceted containment strategy can successfully control outbreaks due to MDR A. baumannii in a burns centre.
Insights
Multi-drug-resistant organism (MDRO) outbreaks in burn centers pose significant risks. A comprehensive strategy involving infection control measures and staff education effectively controlled a multi-drug-resistant Acinetobacter baumannii outbreak.
Area of Science:
- Infectious Disease Epidemiology
- Critical Care Medicine
- Public Health Microbiology
Background:
- Patients in burn centers face elevated risks of multi-drug-resistant organism (MDRO) acquisition due to compromised skin barriers and prolonged hospital stays.
- The study addresses the critical issue of MDRO transmission in vulnerable burn patient populations.
Purpose of the Study:
- To investigate and control an outbreak of multi-drug-resistant Acinetobacter baumannii within a specialized burns center.
- To identify risk factors associated with MDRO acquisition in burn patients during an outbreak.
Main Methods:
- Regular screening of hospitalized patients and environmental sampling to detect MDRO presence.
- Utilized Fourier-transform infra-red (FT-IR) spectroscopy and multi-locus sequence typing for strain characterization.
- Implemented a multi-faceted containment strategy including admission control, isolation, enhanced disinfection, and staff education.
Main Results:
- An outbreak of multi-drug-resistant Acinetobacter baumannii occurred between August and November 2022, affecting eight patients with 11 infections and three fatalities.
- Increased burn surface area (≥2a) was associated with higher acquisition risk, while a higher nurse-to-patient ratio showed a protective effect.
- Environmental sampling did not pinpoint a single common source, suggesting complex transmission dynamics.
Conclusions:
- Burn patients with extensive burn lesions (≥2a) are particularly susceptible to MDRO colonization and infection, especially during high-workload periods.
- A coordinated, multi-disciplinary containment strategy is highly effective in controlling outbreaks of multi-drug-resistant Acinetobacter baumannii in burns units.
More Related Videos
07:41Author Spotlight: A Comprehensive Protocol for Acinetobacter Biofilm Quantification, Assessment, and Visualization
Published on: August 4, 2023
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
